Target intelligence / Profile preview

Multiple bacterial enzymes, cell wall components, and proteins

Molecular classification
Enzyme, Cell wall component (such as peptidoglycan, teichoic acid), Protein (including membrane and secreted proteins), Other
01

Overview

This entry refers collectively to multiple structurally and functionally distinct bacterial molecules, including enzymes like penicillin-binding proteins, peptidoglycan hydrolases, proteases, and various cell wall or membrane proteins. These molecules are integral to bacterial physiology, survival, and virulence, performing roles in cell wall synthesis, maintenance, remodeling, and interaction with the host. Many classical and novel antibiotics, as well as biotherapeutics like lysins and antibody-antibiotic conjugates, target these bacterial components to treat infections. However, the broadness and lack of specificity of this term make it unfit for precise drug target databases, which require unique molecular identifiers for each target. **Note:** The phrasing "Multiple bacterial enzymes, cell wall components, and proteins" is too general and non-canonical for structured data. For research or clinical applications, it should be broken down into specific molecular targets (for example, "penicillin-binding protein 2a" or "peptidoglycan glycosyltransferase") for actionable information.

Other names
Bacterial cell wall enzymesBacterial cell wall proteinsBacterial surface proteinsBacterial enzymes involved in cell wall biosynthesis
02

Mechanism of action

Inhibition of cell wall biosynthesis (e.g., β-lactam antibiotics inhibit penicillin-binding proteins) Disruption of peptidoglycan cross-linking Cleavage of peptidoglycan (e.g., by endolysins, lysostaphin) Inhibition of bacterial protease activity (e.g., β-lactone inhibition of ClpP) Targeted lysis of bacteria by antibody-antibiotic conjugates

03

Biological functions

Cell wall biosynthesisPeptidoglycan remodelingPathogen survival and virulenceProtein secretionImmune evasion
04

Disease associations

InfectionAntimicrobial resistanceInflammation
05

Safety considerations

Off-target effects on human microbiotaResistance development (e.g., β-lactamase production, mutation of target proteins)Potential immunogenicity (for large protein/peptide therapeutics)
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillin, cephalosporins)

5 more in the full profile.

07

Biomarkers

Peptidoglycan subunits (can indicate activity of enzymes or infection)Specific cell wall proteins (used in diagnostics and vaccine research)

Beyond the preview

Go deeper on Multiple bacterial enzymes, cell wall components, and proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple bacterial enzymes, cell wall components, and proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call